1040 Federal Register / Vol. 83, No. 6 / Tuesday, January 9, 2018 / Notices 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Lisa Wright-Solomon, the HRSA 

Information Collection Clearance Officer 

at (301) 443–1984. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

information request collection title for 

reference. 

Information Collection Request Title: 

Radiation Exposure Screening and 

Education Program, OMB No. 0906– 

0012—Revision. 

Abstract: The Radiation Exposure 

Screening and Education Program 

(RESEP) is authorized by section 417C 

of the Public Health Service Act (42 

U.S.C. 285a–9). The purpose of RESEP 

is to assist individuals who live (or 

lived) in areas where U.S. nuclear 

weapons testing occurred and who are 

diagnosed with cancer and other 

radiogenic diseases caused by exposure 

to nuclear fallout or nuclear materials 

such as uranium. RESEP funds support 

eligible health care organizations in 

implementing cancer screening 

programs; developing education 

programs; disseminating information on 

radiogenic diseases and the importance 

of early detection; screening eligible 

individuals for cancer and other 

radiogenic diseases; providing 

appropriate referrals for medical 

treatment; and facilitating 

documentation of radiation exposure. 

Need and Proposed Use of the 

Information: For this program, 

performance measures were drafted to 

provide data useful to the program and 

to enable HRSA to provide aggregate 

program data required by Congress 

under the Government Performance and 

Results Act of 1993 (Pub. L. 103–62). 

These measures cover the principal 

topic areas of interest to the Federal 

Office of Rural Health Policy (FORHP), 

including demographics for the RESEP 

program user population, medical 

screening activities for cancers and 

other radiogenic diseases, exposure and 

presentation types for eligible 

radiogenic malignant and nonmalignant 

diseases, referrals for appropriate 

medical treatment, eligibility counseling 

and referral assistance for the Radiation 

Exposure Compensation Act, and 

program outreach and education 

activities. These measures speak to 

FORHP’s progress toward meeting the 

established goals. In order to reduce the 

reporting burden by the award 

recipients, a number of questions have 

been removed with the new set of 

measures reflecting an effort to 

streamline data collection and collect 

consistent and uniform measures across 

FORHP’s grant programs. 

Likely Respondents: Radiation 

Exposure Screening and Education 

Program award recipients. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to: (1) Review instructions; (2) 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; (3) train 

personnel and to be able to respond to 

a collection of information; (4) search 

data sources; to complete and review 

the collection of information; and (5) 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

Radiation Exposure Screening and Education Program ..... 8 1 8 12 96 

8 ........................ 8 ........................ 96 

HRSA specifically requests comments 

on: (1) The necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–00145 Filed 1–8–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Dental 

and Craniofacial Research Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Dental and Craniofacial Research Council. 

Date: January 31, 2018. 

Open: 8:30 a.m. to 12:00 p.m. 

Agenda: Report to the Director, NIDCR. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 6, 

31 Center Drive, Bethesda, MD 20892. 

Closed: 1:30 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 6, 

31 Center Drive, Bethesda, MD 20892. 

Contact Person: Alicia J. Dombroski, Ph.D., 

Director, Division of Extramural Activities, 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 6 / Tuesday, January 9, 2018 / Notices 1041 

National Institute of Dental and Craniofacial 

Research, National Institutes of Health, 

Bethesda, MD 20892, 301–594–4805, 

adombroski@nidcr.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nidcr.nih.gov/about, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 2, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00155 Filed 1–8–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; MSM Program 

Review (2018/05). 

Date: February 12, 2018. 

Time: 5:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy Plaza, 

Suite 920, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Manana Sukhareva, Ph.D., 

Scientific Review Officer, National Institutes 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Boulevard, Suite 959, Bethesda, 

MD 20892, (301) 451–3397, sukharem@

mail.nih.gov. 

Dated: January 2, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00154 Filed 1–8–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Confidentiality of Substance Use 

Disorder Patient Records 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice of public meeting. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) announces that it will hold 

a public listening session on 

Wednesday, January 31, 2018, to solicit 

information concerning the 

Confidentiality of Substance Use 

Disorder Patient Records regulations as 

required by Section 11002 of the 21st 

Century Cures Act. The listening session 

will provide an opportunity for the 

public to provide input to SAMHSA 

concerning the effect of part 2 on 

‘‘patient care, health outcomes, and 

patient privacy’’ as well as potential 

regulatory changes and future 

subregulatory guidance. 

DATES: The listening session will be 

held on Wednesday, January 31, 2018, 

from 8:30 a.m. (Eastern) to 1:00 p.m. 

(Eastern). 

FOR FURTHER INFORMATION CONTACT: For 

information concerning the listening 

session, please contact Rachel Karton, 

Senior Legislative and Regulatory 

Analyst, SAMHSA, 5600 Fishers Lane, 

Rockville, MD 20857, (240) 276–0416 or 

email PrivacyRegulations@

SAMHSA.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Participation: The Listening Session 

proceeding will be recorded, and 

subsequently archived and posted on 

the SAMHSA website. The public may 

attend the listening session: 

• Via Teleconference/Webcast: The 

entire proceeding will be streamed live 

over the internet (requires prior 

registration). Audio and streaming 

information will be sent to those who 

register prior to the meeting. Capacity 

for the Teleconference/Webcast 

participation is limited so early 

registration is recommended. 

• In Person: The address for this 

meeting is 5600 Fishers Lane, 5th 

(Main) Floor Pavilion rooms, Rockville, 

Maryland 20852. The building is a 

federal facility; prior registration, a 

security screening and a federallyapproved identification (e.g., driver’s 

license) are required to attend in-person. 

Capacity for in-person attendance is 

limited so early registration is 

recommended. 

Registration: Registration is required 

for participation in the listening session 

in person or via Teleconference/ 

Webcast. Registration is now open. 

Registration for the in-person session 

will close on 01/22/2018 at 12:00 p.m. 

Eastern Time (ET). Registration for the 

Teleconference/Webcast will close on 

01/31/2018 at 8:30 a.m. ET. Persons 

registering should indicate if they wish 

to make a public comment. SAMHSA 

recommends that when commenters 

suggest changes or revisions to current 

regulations that they indicate 

specifically, when feasible, how such 

regulation text should be revised. Only 

one representative of an organization 

may be allowed to present oral 

comments. Presentations will be limited 

to three minutes per speaker. SAMHSA 

will try to accommodate all speakers 

who wish to present based on the time 

allotted for this meeting. Persons 

making oral presentations are 

encouraged to also submit written 

comments as discussed below. 

To register, go to: https://42-cfr-part2- 

listening-session.eventbrite.com. 

Special Assistance: Individuals who 

plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify Rachel 

Karton (contact information provided 

below) at least 10 days prior to the 

meeting. 

Public Comments: In addition to 

attending the session in person or 

joining via Teleconference/Webcast, the 

Agency offers several ways to provide 

comments. SAMHSA recommends that 

when commenters suggest changes or 

revisions to current regulations that they 

indicate specifically, when feasible, 

how such regulation text should be 

revised. You may provide comments 

through the following means: 

• Electronically: PrivacyRegulations@

SAMHSA.hhs.gov (preferred). 

• Regular, Express or Overnight Mail, 

or Hand Delivery or Courier: Written 

comments must be sent to the following 

address ONLY: Substance Abuse and 

Mental Health Services Administration 

(SAMHSA), Department of Health and 


sradovich on DSK3GMQ082PROD with NOTICES